⌘K

Login Start Free

Home/Filings/4/0001062993-23-003849

4//SEC Filing

Sherblom James 4

Accession 0001062993-23-003849

CIK 0001907685other

View on SEC.gov Company Profile

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 6:33 PM ET

Size

5.2 KB

Accession

0001062993-23-003849

Insider Transaction Report

Form 4

Period: 2023-02-14

Comera Life Sciences Holdings, Inc.CMRA

Director

Transactions

Award
Stock Option (Right to Purchase)
2023-02-14+7,100→ 7,100 total
Exercise: $1.30Exp: 2033-02-14→ Common Stock (7,100 underlying)

Footnotes (1)

[F1]The stock option vests in 12 equal monthly installments beginning on March 14, 2023 such that the option will be fully vested on February 14, 2024, subject to continuous service to the issuer through each vesting date.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Comera Life Sciences Holdings, Inc.

CIK 0001907685

Entity typeother

Related Parties

1

filerCIK 0001926230

Filing Metadata

Form type: 4
Filed: Feb 15, 7:00 PM ET
Accepted: Feb 16, 6:33 PM ET
Size: 5.2 KB

View on SEC.gov